J.-P. Aboulker

1.1k total citations
14 papers, 444 citations indexed

About

J.-P. Aboulker is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, J.-P. Aboulker has authored 14 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Virology, 8 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in J.-P. Aboulker's work include HIV Research and Treatment (9 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (6 papers). J.-P. Aboulker is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (6 papers). J.-P. Aboulker collaborates with scholars based in France, Mali and United Kingdom. J.-P. Aboulker's co-authors include P. Yéni, Brigitte Autran, J. A. Rioux, Daniel Scott‐Algara, Vincent Meiffrédy, R. Killick‐Kendrick, G. Lanotte, Cyrille Chazallon, Stanislas Pol and David A. Cooper and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Gut.

In The Last Decade

J.-P. Aboulker

13 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.-P. Aboulker France	11	299	222	164	67	49	14	444
Leopoldo Deibis Venezuela	9	195 0.7×	98 0.4×	115 0.7×	96 1.4×	109 2.2×	19	419
Cecilia Tortajada Spain	11	205 0.7×	106 0.5×	122 0.7×	95 1.4×	42 0.9×	18	332
Stacey Chapman United States	9	147 0.5×	98 0.4×	176 1.1×	146 2.2×	23 0.5×	14	329
Chatchawann Apichartpiyakul Thailand	11	197 0.7×	286 1.3×	188 1.1×	102 1.5×	129 2.6×	14	518
Maria Grazia Mancini Italy	11	193 0.6×	209 0.9×	156 1.0×	72 1.1×	63 1.3×	14	362
Teresa García-Benayas Spain	13	395 1.3×	289 1.3×	85 0.5×	29 0.4×	11 0.2×	18	482
L Sighinolfi Italy	9	224 0.7×	159 0.7×	139 0.8×	14 0.2×	34 0.7×	21	365
William E. Maher United States	8	418 1.4×	304 1.4×	93 0.6×	10 0.1×	24 0.5×	14	559
Djeneba Fofana France	14	309 1.0×	264 1.2×	111 0.7×	44 0.7×	14 0.3×	35	420
Alessandro Chiodera Italy	9	135 0.5×	91 0.4×	108 0.7×	86 1.3×	24 0.5×	14	260

Countries citing papers authored by J.-P. Aboulker

Since Specialization

Citations

This map shows the geographic impact of J.-P. Aboulker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-P. Aboulker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-P. Aboulker more than expected).

Fields of papers citing papers by J.-P. Aboulker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-P. Aboulker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-P. Aboulker. The network helps show where J.-P. Aboulker may publish in the future.

Co-authorship network of co-authors of J.-P. Aboulker

This figure shows the co-authorship network connecting the top 25 collaborators of J.-P. Aboulker. A scholar is included among the top collaborators of J.-P. Aboulker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-P. Aboulker. J.-P. Aboulker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Fontaine, Hélène, Sandrine Kahi, Cyrille Chazallon, et al.. (2014). Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial—ANRS HB02 VAC-ADN. Gut. 64(1). 139–147. 78 indexed citations

Delaugerre, Constance, Joseph M. Braun, Isabelle Charreau, et al.. (2012). Comparison of resistance mutation patterns in historical plasma HIV RNA genotypes with those in current proviral HIV DNA genotypes among extensively treated patients with suppressed replication. HIV Medicine. 13(9). 517–525. 55 indexed citations

Fontaine, H., Cyrille Chazallon, Maryline Bourgine, et al.. (2011). 1367 RELAPSE AFTER ANALOGUES TREATMENT DISCONTINUATION IS NOT PREVENTED BY DNA VACCINATION IN CHRONIC HEPATITIS B (ANRS HB 02 VAC-ADN). Journal of Hepatology. 54. S542–S542. 3 indexed citations

Larrouy, Lucile, Corine Chazallon, Roland Landman, et al.. (2010). Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naive HIV-Infected Patients. Antimicrobial Agents and Chemotherapy. 54(7). 2910–2919. 25 indexed citations

Landman, Roland, Catherine Capitant, Diane Descamps, et al.. (2009). Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study. Journal of Antimicrobial Chemotherapy. 64(1). 118–125. 7 indexed citations

Castro, Nathalie De, Joseph M. Braun, Isabelle Charreau, et al.. (2009). H-34 Switch de l’enfuvirtide (ENF) pour le raltegravir (RAL) chez des patients infectés par un VIH multi-résistant et bien contrôlés sous traitement : Résultats de l’essai Easier-ANRS 138. Médecine et Maladies Infectieuses. 39. S45–S45.

Samri, Assia, Christine Durier, Alejandra Urrutia, et al.. (2006). Evaluation of the Interlaboratory Concordance in Quantification of Human Immunodeficiency Virus-Specific T Cells with a Gamma Interferon Enzyme-Linked Immunospot Assay. Clinical and Vaccine Immunology. 13(6). 684–697. 23 indexed citations

Yéni, P., David A. Cooper, J.-P. Aboulker, et al.. (2006). Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial. The Lancet. 368(9532). 287–298. 72 indexed citations

Aboulker, J.-P.. (2004). Highly active antiretroviral therapy started in infants under 3 months of age. AIDS. 18(2). 237–245. 59 indexed citations

10.

Scott‐Algara, Daniel, J.-P. Aboulker, Christine Durier, et al.. (2001). CD4 T cell recovery is slower in patients experiencing viral load rebounds during HAART. Clinical & Experimental Immunology. 126(2). 295–303. 12 indexed citations

11.

Aubry, P, Isabelle Carrière, N Mlika-Cabanne, et al.. (1996). Randomized Comparison of Amphotericin B Deoxycholate Dissolved in Dextrose or Intralipid for the Treatment of AIDS-Associated Cryptococcal Meningitis. Clinical Infectious Diseases. 23(3). 556–562. 36 indexed citations

12.

Aboulker, J.-P., Brigitte Autran, Kheïra Beldjord, F. Touraine, & Patrice Debré. (1992). Consistency of routine measurements of CD4+, CD8+ peripheral blood lymphocytes. Journal of Immunological Methods. 154(2). 155–161. 25 indexed citations

13.

Rioux, J. A., et al.. (1985). Écologie des leishmanioses dans le sud de la France. Annales de Parasitologie Humaine et Comparée. 60(3). 221–229. 35 indexed citations

14.

Papoz, L, Didier Job, É. Eschwège, et al.. (1978). Effect of oral hypoglycaemic drugs on glucose tolerance and insulin secretion in borderline diabetic patients. Diabetologia. 15(5). 373–380. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact